Lifeward Ltd (NASDAQ: LFWD) on Tuesday, soared 9.22% from the previous trading day, before settling in for the closing price of $0.63. Within the past 52 weeks, LFWD’s price has moved between $0.50 and $2.95.
Annual sales at Healthcare sector company grew by 29.33% over the past five years. The company achieved an average annual earnings per share of 73.27%. With a float of $17.85 million, this company’s outstanding shares have now reached $18.29 million.
Lifeward Ltd (LFWD) Insider and Institutional Ownership
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Lifeward Ltd is 2.42%, while institutional ownership is 4.21%. The most recent insider transaction that took place on Sep 02 ’25, was worth 1,018. In this transaction VP of Market Access & Strategy of this company sold 1,591 shares at a rate of $0.64, taking the stock ownership to the 46,067 shares. Before that another transaction happened on May 21 ’25, when Company’s Chief Executive Officer sold 1,909 for $1.26, making the entire transaction worth $2,405. This insider now owns 98,728 shares in total.
Lifeward Ltd (LFWD) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.38 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.33) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.27% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 80.42% during the next five years compared to 29.33% growth over the previous five years of trading.
Lifeward Ltd (NASDAQ: LFWD) Trading Performance Indicators
Lifeward Ltd (LFWD) is currently performing well based on its current performance indicators. A quick ratio of 1.13 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.98, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.23 in one year’s time.
